Tapewire

Nasdaq · USD

SLS

SELLAS Life Sciences Group, Inc.

Export transactions ↓
Tapewire entity
4313
SEC CIK
0001390478
Parsed reports
165

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 17, 2017 Filed Jan 19, 2017 17:17 UTC
Knapp Thomas JGeneral Counsel
GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $1.81 $0.00
Disclosure

SEC source: 0001394548-17-000002 · primary_doc.xml · derivative · entry 1

Knapp Thomas J · CIK 0001311726 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2027-01-17

F1 · security: Granted pursuant to the Issuer's 2016 Incentive Plan.

F2 · derivative.exercise_date: This stock option will vest in 16 equal, quarterly installments over four years beginning three months from the date of grant, so long as the Reporting Person remains in the company's continuous employ through the vesting period.

Read SEC document
January 17, 2017 Filed Jan 19, 2017 22:12 UTC
Burns John ThomasVice President, Finance
GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.81 $0.00
Disclosure

SEC source: 0001394548-17-000001 · primary_doc.xml · derivative · entry 1

Burns John Thomas · CIK 0001568734 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2027-01-17

F1 · security: Granted pursuant to the Issuer's 2016 Incentive Plan.

F2 · derivative.exercise_date: This stock option will vest in 16 equal, quarterly installments over four years beginning three months from the date of grant, so long as the Reporting Person remains in the company's continuous employ through the vesting period.

Read SEC document
November 01, 2016 Filed Nov 15, 2016 23:26 UTC
Ghiglieri Stephen FChief Financial Officer
GrantStock Option (right to buy) · Derivative 1,000,000 $0.00 Strike: $0.19 $0.00
Disclosure

SEC source: 0001394548-16-000003 · primary_doc.xml · derivative · entry 1

Ghiglieri Stephen F · CIK 0001394548 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2026-11-01

F1 · security: Granted pursuant to the Issuer's 2016 Incentive Plan.

F2 · shares: The Reporting Person obtained the securities pursuant to a new hire Employment Agreement dated November 1, 2016. The securities were convertible into common stock at the rate of 1 share of common stock for each 1 stock option share, or an aggregate 1,000,000 shares of common stock (pre-reverse stock split). The securities were converted into 50,000 stock options at a price of $3.80 (post-reverse stock split) as of November 14, 2016.

F3 · derivative.exercise_date: This stock option vests in equal, quarterly installments over four years, beginning three months after November 1, 2016.

Read SEC document
October 25, 2016 Filed Dec 20, 2016 17:12 UTC
Knapp Thomas JGeneral Counsel
GrantStock Option (right to buy) · Derivative 102,000 $0.00 Strike: $0.29 $0.00
Disclosure

SEC source: 0001394548-16-000004 · primary_doc.xml · derivative · entry 1

Knapp Thomas J · CIK 0001311726 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,000

Underlying: Common Stock · 102,000 shares

Expires 2026-10-25

F1 · security: Granted pursuant to the Issuer's 2016 Incentive Plan.

F2 · shares: The Reporting Person obtained the securities pursuant to an Employment Agreement Amendment dated October 1, 2016. The securities were convertible into common stock at the rate of 1 share of common stock for each 1 stock option share, or an aggregate of 102,000 shares of common stock (pre-reverse stock split). The securities were converted into 5,100 stock options at a price of $5.744 per share (post-reverse split) as of November 14, 2016.

F3 · derivative.exercise_date: This stock option vests in equal monthly installments beginning November 25, 2016 and ending March 31, 2017.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.